Skip to content

Intake behavior of nicotine in venous blood in electric cigarettes in the acute phase

Intake behavior of nicotine in venous blood in electric cigarettes in the acute phase - Nico-Tide

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00017432
Enrollment
45
Registered
2019-06-06
Start date
2020-01-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F17.2

Interventions

Group 1: E-Cigarette Juul Vaper. According to the study protocol, the first 5 minutes of a standardized use of the Juul blood should be taken and its concentration of nicotine should be determined at

Sponsors

Klinik für Psychiatrie und Psychotherapie des Klinikums der Ludwigs-Maximilians Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion / exclusion criteria General inclusion criteria: • Subjects between 18 and 55 years • 12-hour abstinence (both e-cigarette users and tobacco smokers) • CO 3 months, daily consumption • no consumption of conventional tobacco cigarettes for > 3 months Special inclusion criteria for smokers • Smoker for > 5 years daily > 10 cigarettes / day

Exclusion criteria

Exclusion criteria: Exclusion criteria • Patients under the age of 18 or over 55 years • acute psychiatric disorders according to ICD-10 / DSM IV • other serious psychiatric illnesses • acute suicidality • existing pregnancy • Drug, drug or alcohol abuse at the time of the study • current malignancies in the last 5 years • severe internal diseases, especially cardiovascular diseases, such as -- manifest arterial hypertension -- severe heart disease (DCM, history of a heart attack) -- pacemaker -- respiratory failure • severe active infectious diseases • CO> 5 ppm in the expirium • other circumstances that, in the investigator's opinion, militate against patient participation in this study

Design outcomes

Primary

MeasureTime frame
Assessment of the speed and concentration of nicotine infiltration of the E-cigarette JUUL compared to the conventional tobacco cigarette in the acute phase at 5 measurement times.

Secondary

MeasureTime frame
Assessment of the addictive potential, since drug infiltration and concentration strongly correlate with the addictive potential.

Countries

Germany

Contacts

Public ContactAndrea Rabenstein

Klinik für Psychiatrie und Psychotherapie des Klinikums der Ludwis-Maximilian Universität München

Andrea.Rabenstein@med.uni-muenchen.de089440055545

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026